Skip to content
★ Sign in to follow
DT

Daniel T. London

Accenture plcAccenture Holdings plc
Total declarations
171
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (44 ops.)
€10.3M

Latest filing published 19 Feb 2020 for Accenture plc, €979.

Filing timeline

BuySale
Daniel T. London

Insider track record

Disclosed buys
0
Disclosed sells
44
Signal history

Daniel T. London: trading record in brief

Daniel T. London discloses dealings in 2 companies, chiefly Accenture plc and Accenture Holdings plc. We count 171 filings; the first trade dates from 5 June 2014 and the latest from 14 February 2020.

No open-market purchase appears, only 44 sales worth €10.3M. The rest of the record consists of 123 share grants. Since January 2020: no purchases and 3 sales on the market.

The latest filing, published on 19 February 2020, reports a share grant of €979 in Accenture plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Daniel T. London

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations170 total
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    1,062 USD11SEC
    5 shares@ US$212.440.0% of flowClass A ordinary sharesSEC:0001467373-20-000128:1
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    0SEC
    23 shares0Class A ordinary sharesSEC:0001467373-20-000128:0
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    198,331 USD11SEC
    959 shares@ US$206.812.3% of flowClass A ordinary sharesSEC:0001467373-20-000071:0
  • ▼
    Group Chief Exec - Health & PSExecutivesAccenture plc
    62,617 USD29SEC
    301 shares@ US$208.030.7% of flowClass A ordinary sharesSEC:0001467373-20-000031:0
  • ▼
    Group Chief Exec - Health & PSExecutivesAccenture plc
    1M USD30SEC
    6,316 shares@ US$209.1014.4% of flowClass A ordinary sharesSEC:0001467373-20-000031:1
  • ▼
    Group Chief Exec - Health & PSExecutivesAccenture plc
    373,913 USD29SEC
    1,783 shares@ US$209.714.1% of flowClass A ordinary sharesSEC:0001467373-20-000031:2
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    139,694 USD11SEC
    669 shares@ US$208.811.5% of flowClass A ordinary sharesSEC:0001467373-20-000018:0
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    0SEC
    3,567 shares0Class A ordinary sharesSEC:0001467373-20-000006:0
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    121,314 USD11SEC
    577 shares@ US$210.251.3% of flowClass A ordinary sharesSEC:0001467373-20-000006:1
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    0SEC
    96 shares0Class A ordinary sharesSEC:0001467373-19-000361:0
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    6,294 USD11SEC
    32 shares@ US$196.690.1% of flowClass A ordinary sharesSEC:0001467373-19-000361:1
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    26,330 USD11SEC
    141 shares@ US$186.740.3% of flowClass A ordinary sharesSEC:0001467373-19-000347:0
  • ▼
    Group Chief Exec - Health & PSExecutivesAccenture plc
    556,926 USD30SEC
    3,007 shares@ US$185.215.9% of flowClass A ordinary sharesSEC:0001467373-19-000334:0
  • ▼
    Group Chief Exec - Health & PSExecutivesAccenture plc
    387,813 USD29SEC
    2,083 shares@ US$186.184.1% of flowClass A ordinary sharesSEC:0001467373-19-000334:1
  • ▼
    Group Chief Exec - Health & PSExecutivesAccenture plc
    61,857 USD29SEC
    331 shares@ US$186.880.7% of flowClass A ordinary sharesSEC:0001467373-19-000334:2
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    0SEC
    17,171 shares0Class A ordinary sharesSEC:0001467373-19-000321:0
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    1M USD13SEC
    7,748 shares@ US$185.2315.1% of flowClass A ordinary sharesSEC:0001467373-19-000321:1
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    26,126 USD11SEC
    139 shares@ US$187.960.3% of flowClass A ordinary sharesSEC:0001467373-19-000291:0
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    26,285 USD11SEC
    132 shares@ US$199.130.3% of flowClass A ordinary sharesSEC:0001467373-19-000265:0
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    26,267 USD11SEC
    140 shares@ US$187.620.3% of flowClass A ordinary sharesSEC:0001467373-19-000250:0
  • ▼
    Group Chief Exec - Health & PSExecutivesAccenture plc
    110,209 USD29SEC
    588 shares@ US$187.431.1% of flowClass A ordinary sharesSEC:0001467373-19-000250:1
  • ▼
    Group Chief Exec - Health & PSExecutivesAccenture plc
    269,909 USD29SEC
    1,435 shares@ US$188.092.8% of flowClass A ordinary sharesSEC:0001467373-19-000250:2
  • ▼
    Group Chief Exec - Health & PSExecutivesAccenture plc
    49,150 USD29SEC
    260 shares@ US$189.040.5% of flowClass A ordinary sharesSEC:0001467373-19-000250:3
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    26,220 USD11SEC
    138 shares@ US$190.000.3% of flowClass A ordinary sharesSEC:0001467373-19-000225:0
  • ◆
    Group Chief Exec - Health & PSExecutivesAccenture plc
    26,367 USD11SEC
    147 shares@ US$179.370.3% of flowClass A ordinary sharesSEC:0001467373-19-000205:0

25 of 170 declarations